INDICATION OF HPV VACCINE IN THE TREATMENT OF A CHILD WITH RECURRENT LARYNGEAL PAPILLOMATOSIS
INDICATION (Português (Brasil))

Keywords

Papillomatosis. HPV. Laryngeal neoplasms. Vaccine.

How to Cite

Letícia Ferreira, B. ., Maurícia Souza, L. ., Aparecida Alves Barbosa, R. ., Cristina Teixeira, C., de Freitas Villela, M. ., Coutinho Ferreira, C. ., Kelly Duarte de Oliveira Lopes, G. ., Rocha de Oliveira, B. ., Felipe Antunes da Silva, L. ., Gabrielle Rodrigues Peixoto, S. ., Emanuelle Rocha dos Santos, H. ., Gonçalves Silva Pereira, S. ., Clara Dias Mendes, A. ., Geovania Souza, K. ., Ferreira da Silva Albuquerque, I. ., Tatiane Pereira de Jesus Ribeiro, K. ., & Gonçalves de Souza, S. . (2024). INDICATION OF HPV VACCINE IN THE TREATMENT OF A CHILD WITH RECURRENT LARYNGEAL PAPILLOMATOSIS: A CASE STUDY. Health and Society, 4(01), 129–138. https://doi.org/10.51249/hs.v4i01.1840

Abstract

Laryngeal papillomatosis or Recurrent Respiratory Papillomatosis (PRR) is the main cause of benign laryngeal neoplasia characterized by the proliferation of epithelial lesions with the presence of warts, called papillomas. These are often multiple and recurrent, being caused by The Human Papilloma Virus (HPV). Currently, there are no surgical or curative medical treatments for the disease. The literature indicates several options, including the quadrivalent HPV vaccine. In this sense, this study sought to report a clinical case of a child with recurrent respiratory papillomatosis, with emphasis on the quadrivalent HPV vaccine used as adjuvant therapy. In this case study, it was evidenced that immunization can be used as adjuvant therapy.

https://doi.org/10.51249/hs.v4i01.1840
INDICATION (Português (Brasil))

References

AVELINO, M.; ZAIDEN, T.; GOMES, R. Surgical treatment and adjuvante therapies of recurrent respiratory papillomatosis. Revista de Otorrinolaringologia. v. 79, n. 12. p.636-642, 2013.

CASTILLO, H et al. Papilomatosis laríngea juvenil y su relación com la infección genital por vírus de papiloma humano durante el embarazo. Revista de Ginecologia e Obstetrícia. v. 75, n. 4, p.260-268, 2015.

CARIFI M, Napolitano D, MORANDI. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. v.5, n.11, p.731-738, 2015.

FERRARIA, L. Recidiva da papilomatose laríngea após tratamento cirúrgico, Revista Portugues de otorrinolaringologia e cirurgia cérvico-facial. Revista Portuguesa de Otorrinolaringologia e Cirurgia Cérvico-Facial. v.55, n.3, p.155-162, 2017.

GUEDES, M et al. A vacina do papilomavírus humano e o câncer do colo do útero: uma reflexão. Revista de enfermagem UFPE on line. v. 11, n.12, p.224-231, 2017.

RIBALTA, J.C.L. et al. Papilomavírus humano – Qual o risco de transmissão para o feto? Qual a conduta com a gestante? Femina. v. 30, n. 4, p. 243-248, 2002.

SEDAGHAT, N.S. Papilomatosis respiratoria recurrente y el rol de la vacunación antiVPH. Revista de Otorrinolaringologia Cabeça e Pescoço. v.73, n.1, p. 89-93, 2013.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Bruna Letícia Ferreira, Luanna Maurícia Souza, Romana Aparecida Alves Barbosa, Claudia Cristina Teixeira, Matheus de Freitas Villela, Cinara Coutinho Ferreira, Greicy Kelly Duarte de Oliveira Lopes, Bryan Rocha de Oliveira, Leandro Felipe Antunes da Silva, Sarah Gabrielle Rodrigues Peixoto, Hanna Emanuelle Rocha dos Santos, Sabrina Gonçalves Silva Pereira, Ana Clara Dias Mendes, Karla Geovania Souza, Ivani Ferreira da Silva Albuquerque, Kelly Tatiane Pereira de Jesus Ribeiro, Sabrina Gonçalves de Souza

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...